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ABSTRACT
Objectives: The aim of the present study is to determine the predictive value of Computed Tomography (CT), alone or 
in combination with serum CA-125 levels, for preoperative staging, detection of the extent of the disease, and surgical 
complications in patients with ovarian carcinoma.
Material and methods: One hundred and fourteen patients diagnosed with ovarian carcinoma following an exploratory 
laparotomy with a preoperative CT scan, performed between January 2007 and June 2013, were enrolled in the study. 
Preoperative CT and intraoperative surgical findings were compared using 14 parameters and predictions of CT for gas-
trointestinal, genitourinary, and cardiovascular complications. All radiological features and clinical characteristics were 
analyzed statistically.
Results: CT and surgical findings correlated (sensitivity/ specificity) as follows: uterine and tubal spread (66%/89%), cervical 
involvement (100%/80%), peritoneal nodulesincreased density-carcinomatosis (57%/93%), omental involvement (68%/95%), 
retroperitoneal involvement (25%/84%), ascites (85%/87%), perirectal and perivesical fat plan obliteration (43%/94%), liver 
metastasis (50%/91%), small and large bowel involvement (47%/95%), adnexal mass (94%/70%), and other metastases 
(47%/86%). Also, CT findings were found to be statistically insignificant for prediction of mesenteric involvement, bladder 
metastasis, and diaphragmatic involvement. The overall CT sensitivity and specificity at detecting intraoperative findings 
was 91% and 71%, respectively. We found a statistically significant correlation between intestinal involvement on CT and 
the necessity of additional surgical procedures.
Conclusions: CT is a widely used imaging method in the preoperative evaluation of ovarian cancer. However, its predictive 
value, sensitivity and specificity differ, depending on the anatomical region.
Key words: computed tomography, complication, prediction, ovarian carcinoma, cytoreductive surgery, radiologic imaging
Ginekologia Polska 2016; 87, 5: 326–332
Corresponding author:
Derya Kilic Sakarya 
Yukari Distinc, Fevzi Pasa Street, Number 140/24, Mail box 69, Bozkir, Konya, Turkey 35430
tel.: 0 506 8654499, e-mail: deryakilicsakarya@gmail.com
INTRODUCTION
Ovarian cancer (OC) is the most lethal among all gy-
necological malignancies, with the overall lifetime risk of 
developing cancer estimated at 1.8% [1]. Despite years of 
OC research, the mortality rates could not be reduced. Un-
fortunately, over 70% of the affected patients are diagnosed 
at advanced stages of the disease and long-term survival 
rates are quite low (10–30%) [2]. Accurate determination of 
the disease spread during the preoperative period will result 
in maximum benefit from the treatment by providing the 
necessary conditions for optimal debulking. In addition, it is 
a well-known fact that surgical debulking is the cornerstone 
of therapy and that minimal residual disease after initial 
surgery is the most important factor in increasing chemo-
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therapy response, and consequently the survival rates, for 
women with OC [3, 4].
Various radiological and serological diagnostic methods 
are used to identify high-risk patients, to term peri-operative 
complications, to predict optimal cytoreduction, and to 
identify patients who may benefit from the neo-adjuvant 
therapy. However, none of the methods proved to have 
sufficient predictive value [5–7]. Due to reasonable costs 
and wide availability, Computed Tomography (CT) is one of 
the most commonly used imaging methods and CA-125 is 
the most studied serological marker in OC for this purpose 
[8–10]. Preoperative CT scans can identify the presence of 
the disease in anatomic regions which are difficult to resect, 
i.e. perirectal-perivesical fat plan, bladder, retroperitoneal 
lymph node, small and large intestines, diaphragm, lesser 
sac, liver, mesentery, adenopathy above the renal vessels, 
etc.). Nevertheless, as might be expected, it does not always 
yield the same quality [5, 9, 11].
In our study, we aimed to determine the sensitivity and 
specificity of CT, alone or in combination with serum CA-
-125 levels, to detect the spread of the disease based on 
the organs.
MATERIAL AND METHODS
The study was performed retrospectively in the coopera-
tion of the Gynecology-Oncology and Radiology Depart-
ments at Katip Celebi University and Izmir Ataturk Teaching 
and Research Hospital. A total of 114 patients (aged 28–91) 
diagnosed with ovarian carcinoma following an exploratory 
laparotomy with a preoperative CT scan between January 
2007 and June 2013, were enrolled. Laparotomy was per-
formed in all patients by at least two experts in the field of 
oncological gynecology. The surgical procedures included: 
cytological sampling, if there is a uterus; total abdominal 
hysterectomy, bilateral/unilateral salpingo-oophorectomy, 
partial/total omentectomy, pelvic and para-aortic lymph 
node dissection and, where necessary, maximum tumor 
resection in order to do primary cytoreductive surgery. Only 
the patients with the preoperative CT scans of the pelvis and 
abdomen with oral and iv contrasts performed 4 weeks prior 
to primary surgery at the latest were included in the study. 
Surgical stages of all the patients according to FIGO (Inter-
national Federation of Obstetrics and Gynecology) based 
on intraoperative findings and histopathological data were 
recorded. Preoperative staging was done by evaluation of 
CT examinations based on FIGO staging system. Preopera-
tive CT scans were re-reviewed by one radiologist, who was 
blinded to the previous surgical outcomes. Patient serum 
CA-125 levels were analyzed by the Department of Biochem-
istry using the chemiluminescence method, with normal 
values between 0–35 IU/mL. Testing for CA-125 levels was 
performed within 4 weeks prior to surgery at the latest.
Preoperative CT findings and intraoperative surgical 
findings were compared for 14 parameters. These param-
eters were: adnexal mass, depiction, presence of ascites, 
uterine and tubal invasion, cervical invasion, perirec-
tal-perivesical fat plan obliteration, bladder metastasis, 
peritoneal nodules-diffuse peritoneal thickening, omental 
involvement, retroperitoneal lymph node involvement, the 
involvement of small and large intestine, mesenteric involve-
ment, diaphragmatic involvement, liver involvement, and 
other respectively. 
According to the serum CA-125 levels, compliance of the 
CT findings with intraoperative findings was investigated 
and preoperative CT findings were compared with gas-
trointestinal system (GIS), genitourinary system (GUS) and 
cardiovascular system (CVS) complications and additional 
surgeries respectively.
Statistical analysis was performed using SPSS 15.0 for 
Windows (SPSS Inc, Chicago, III, USA) statistical software. 
Categorical variables were described using frequency distri-
bution. Receiver Operating Characteristic plots (ROC) were 
graphed and the Area Under the Curve (AUC) was calcu-
lated for each categorical variable. Sensitivity and specific-
ity were calculated based on the ROC analysis. Wilcoxon 
signed rank analyses was used to compare preoperative and 
post-operative stages. The p-value of < 0.05 was considered 
as statistically significant.
RESULTS
Mean patient age was 59 years (range 28–91). Histo-
pathological characteristics of the patients were summa-
rized in Table 1. Preoperative serum CA-125 levels ranged 
from 5 U/mL to 6716 U/mL. Twenty-one (21%) patients were 
FIGO stage 1, 4 (4%) were stage 2, 47 (41%) were stage 3, 
and 39 (34%) were stage 4 surgically.
We compared 14 parameters depicting the extent of 
the disease across preoperative CT findings and surgical 
findings. CT sensitivity and specificity for each parameter 
were calculated and are shown in Table 2.
According to the ROC analysis, uterine and tubal spread 
was found in 55 patients intraoperatively. In 36 of them 
these conditions could be detected correctly by preopera-
tive CT. Forty-one patients did not have uterine and tubal 
Table 1. Histopathological range
Histopathological type n %
Epithelial 98 86.0
Germ cell 3 2.6
Metastatic 10 8.8
Sex-cord stromal 3 2.6
114 100.0
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Table 2. The compliance of intraoperative findings and CT findings according to ROC analysis
CT
Intraoperative
Total
Sensitivity Specificity AUC AUCp
+ –
n % n % n %
Uterine-fallopian involvement
+ 36 65.5 7 17.1 43 44.8
65.5 82.9 0.742 0.001– 19 34.5 34 82.9 53 55.2
Total 55 57.3 41 42.7 96 100.0
Cervical involvement
+ 5 100.0 5 20.0 10 33.3
100.0 80.0 0.900 0.005– – – 20 80.0 20 66.7
Total 5 16.7 25 83.3 30 100.0
Peritoneal carcinomatosis
+ 35 57.4 4 7.8 39 34.8
57.4 92.2 0.748 0.001– 26 42.6 47 92.2 73 65.2
Total 61 54.5 51 45.5 112 100.0
Omental involvement 
+ 36 67.9 3 5.2 39 35.1
67.9 94.8 0.814 0.001– 17 32.1 55 94.8 72 64.9
Total 53 47.7 58 52.3 111 100.0
Retroperitoneal involvement
+ 11 25.0 7 15.2 18 20.0
25.0 84.8 0.549 0.424– 33 75.0 39 84.8 72 80.0
Total 44 48.9 46 51.1 90 100.0
Ascites
+ 52 85.2 7 13.5 59 52.2
85.2 86.5 0.859 0.001– 9 14.8 45 86.5 54 47.8
Total 61 54.0 52 46.0 113 100.0
Perivesical-perirectal fat 
plan obliteration
+ 23 42.6 2 3.6 25 22.9
42.6 96.4 0.695 0.001– 31 57.4 53 96.4 84 77.1
Total 54 49.5 55 50.5 109 100.0
Diaphragmatic involvement
+ – – 1 1.2 1 1.0
0.0 98.8 0.494 0.832– 20 100.0 80 98.8 100 99.0
Total 20 19.8 81 80.2 101 100.0
Liver involvement
+ 15 50.0 7 9.1 22 20.6
50.0 90.9 0.705 0.001– 15 50.0 70 90.9 85 79.4
Total 30 28.0 77 72.0 107 100.0
Bladder involvement
+ 7 31.8 9 11.3 16 15.7
31.8 88.8 0.603 0.141– 15 68.2 71 88.8 86 84.3
Total 22 21.6 80 78.4 102 100.0
Small and large bowel 
involvement
+ 22 46.8 3 4.9 25 23.1
46.8 95.1 0.709 0.001– 25 53.2 58 95.1 83 76.9
Total 47 43.5 61 56.5 108 100.0
Mesenteric involvement
+ 12 24.5 4 7.7 16 15.8
24.5 92.3 0.584 0.146– 37 75.5 48 92.3 85 84.2
Total 49 48.5 52 51.5 101 100.0
Other distant metastasis
+ 9 47.4 13 13.7 22 19.3
47.4 86.3 0.668 0.021– 10 52.6 82 86.3 92 80.7
Total 19 16.7 95 83.3 114 100.0
Adnexal mass
+ 88 93.6 3 30.0 91 87.5
93.6 70.0 0.818 0.001– 6 6.4 7 70.0 13 12.5
Total 94 90.4 10 9.6 104 100.0
CT — computed tomography, AUC — area under curve
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spread, and in 7 of them CT yielded false-positive results 
(66% sensitivity, 89% specificity). Cervical involvement could 
be detected intraoperatively with CT in all of the 5 affected 
patients. However, 5 of the 25 patients without cervical 
involvement had false-positive results on CT (100% sensitiv-
ity, 80% specificity). Peritoneal nodules-diffuse peritoneal 
thickening was found in 61 patients intraoperatively and 
CT could detect 35 of these patients correctly. Four patients 
without peritoneal nodules had false-positive results on 
preoperative CT (57% sensitivity, 93% specificity). Thirty-six 
of the 53 patients with omental involvement could be iden-
tified correctly with CT, but 3 of the 51 patients without 
omental involvement had false-positive results on CT (68% 
sensitivity, 95% specificity). CT detected just 11 of the 44 pa-
tients with intraoperatively and histopathologically proven 
retroperitoneal involvement (iliac, obturator, para-aortic 
involvement), and yielded false-positive results in 7 of the 
46 patients without retroperitoneal involvement (25% sen-
sitivity). Ascites was determined correctly by CT in 52 of the 
61 patients. However, CT also yielded false-positive results 
in 7 of the 52 patients without ascites (85% sensitivity, 87% 
specificity). Twenty-three of the 54 patients with perirectal 
and perivesical fat plan obliteration were identified by CT 
correctly, and 2 of the 55 patients without perirectal and 
perivesical fat plan obliteration had false-positive results 
on CT (43% sensitivity and 94% specificity). CT was unable 
to detect any of the 20 patients who had diaphragmatic in-
volvement. Also, 1 of the 81 patients without diaphragmatic 
involvement had false-positive results on CT. CT findings 
were not statistically significant for predicting diaphrag-
matic involvement. CT detected 15 of the 30 patients who 
had liver metastasis, However, it yielded false-positive re-
sults in 7 of the 77 patients without liver metastasis (50% 
sensitivity, 91% specificity). Seven of the 22 patients with 
bladder metastasis were correctly identified by CT, whereas 
9 of the 80 patients without metastasis were found to have 
false-positive results on CT. CT findings were not statistically 
significant for predicting bladder metastasis. CT detected 
22 of the 47 patients who had small and large bowel in-
volvement, but it yielded false-positive results in 3 of the 
47 patients without small and large bowel involvement 
(47% sensitivity, 95% specificity). Twelve of the 49 patients 
with mesenteric involvement were detected by CT cor-
rectly, whereas 4 of the 52 patients without mesenteric 
involvement had false-positive results on CT. CT findings 
were not statistically significant for predicting mesenteric 
involvement. CT detected 9 of the 19 patients who had 
other metastases, and it yielded false-positive results in 
13 of the 95 patients without other metastases (47% sensi-
tivity, 86% specificity). Eighty-eight of the 94 patients with 
adnexal mass could be detected with CT. However, CT 
yielded false-positive results in 3 of the 7 patients without 
adnexal mass (sensitivity 94%, specificity 70%). When all 
parameters are considered, CT findings were statistically 
significantly correlated with intraoperative findings. Con-
sidering all parameters, the overall sensitivity and specificity 
of CT for detection of intraoperative findings were 91% and 
71%, respectively (Figure 1). At the determined cut off value 
of CA-125, the compliance of CT results with intraopera-
tive findings was statistically significant. At CA-125 values 
of > 76.5 IU/mL, CT could detect 79.8% of intraoperative 
findings (AUC) (Figure 2). 
As far as the comparison of preoperative staging with 
surgical staging is concerned, we found that staging with 
CT was correct in 16 of the 23 surgically stage I patients, in 
1 of the 4 surgically stage II patients, in 22 of the 47 surgi-
cally stage III patients, and in 16 of 38 surgically stage IV 
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Figure 1. ROC curve of CT in detecting intraoperative findings
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Figure 2. ROC curve of CT in detecting intraoperative findings 
according to CA-125 (cut off value: 76.5)
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patients. The distribution of preoperative and surgical stages 
is shown in Figure 3. The total sensitivity of CT for staging 
was estimated at 49.1%. When the patients were grouped 
as early (I and II) and late (III and IV) stages, sensitivity and 
specificity of preoperative staging with CT were calculated 
as 81% and 77%, respectively. 
In order to assess the reliability of preoperative CT for 
detection of potential complications of the surgery and 
additional interventions required, we analyzed preopera-
tive CT findings based on complications occurring in GIS, 
GUS and CVS and requirement of additional surgeries. We 
detected a statistically significant correlation between CT 
results and intraoperative findings regarding small and large 
bowel involvement.
The analysis of GIS complications and the need of ad-
ditional surgical procedures, in comparison with preopera-
tive CT findings of GIS, detected a statistically significant 
correlation of CT findings related to small-large bowel and 
liver (superficial and parenchymal) involvement with intra-
operative complications and requirement for additional 
surgical procedures (small and large bowel resection, liver 
resection) (AUC: 0.670, p < 0.05).
The analysis of CT findings related to GUS (uterine and 
tubal spread, bladder involvement, perirectal and perivesical 
fat plan obliteration), in comparison with GUS complica-
tions, found no statistically significant correlation between 
them, and none of the findings was predictive for the re-
quirement of additional surgical procedures (p > 0.05).
In order to assess the predictability of potential com-
plications of CVS, CT findings related to the retroperitoneal 
area were evaluated, and no statistically significant sensitiv-
ity was found (p > 0.05).
DISCUSSION
Surgical staging, as well as cytoreductive surgery, is criti-
cal as it affects the success of the treatment and prognosis [4, 
12]. Determination of the extent of the disease preoperative-
ly will allow to choose the best treatment strategy in clinical 
practice and identify the necessary surgical procedures in 
order to be prepared for them during the preoperative 
period. Due to reasonable costs and wide availability, CT 
is a commonly used imaging method in the preoperative 
evaluation, staging, and treatment planning of OC. However, 
it is insufficient to predict the correct stage as accuracy rates 
are reported between 50% to 92% in some series [8, 11, 13]. 
This may be due to the fact that CT evaluative capabilities 
for each anatomic region are different. Interpretation of 
CT findings would be more accurate if we were to know at 
which part of the examination it is more successful.
For the pelvis, a CT scan allows characterization of the 
adnexal mass and detection of the involvement of any sur-
rounding organs (cervix, bladder, ureter, rectum, sigmoid, 
pelvic sidewall involvement). Regarding the upper abdomi-
nal region, involvement of the peritoneum, omentum, mes-
entery, small and large intestine, intra-extra parenchymal 
liver, diaphragm and retroperitoneal area can be detected 
by i.v. contrast CT scans [14]. However, it is a well-known 
fact that the most important limitation of CT in preoperative 
staging of OC is its inability to detect bowel surface, mesen-
teric, or peritoneal implants of < 5 mm reliably, especially in 
the absence of ascites [15, 16]. In our study, the success rate 
of preoperative CT for prediction of postoperative surgical 
stage was estimated at 49%.
To date, several studies have attempted to establish 
a predictive preoperative model to estimate successful tu-
mor resectability, as well as to find predictors of suboptimal 
cytoreduction [8, 10, 11, 14]. Fujwara et al., aimed to identify 
features of preoperative CT scans which can predict the 
outcomes of primary cytoreductive surgery in OC patients 
most successfully. They created 2 predictive models both in-
cluding diffuse peritoneal thickening, infrarenal para-aortic 
or pelvic lymph node involvement, a bowel encasement 
tumor (≥ 2 cm), and any tumor implants in the cul-de-sac. 
The accuracy rates of the models were 90.8% and 93.9% 
retrospectively [14]. For the same purpose, Bristow et al., 
identified 13 diagnostic features (peritoneal thickening, 
peritoneal implants > 2 cm, small and large bowel mes-
enteric disease > 2 cm, omental extension to stomach, 
spleen, or lesser sac, extension of the tumor to the pelvic 
sidewall/parametria/hydroureter, large-volume ascites, su-
pra- and infrarenal lymph-adenopathy, diaphragm involve-
ment, inguinal canal disease, liver lesions > 2 cm, and porta 
hepatis/gallbladder disease) and calculated the predictive 
score to predict the chances of optimal cytoreduction. Using 
this model, the authors were able to predict the surgical out-
come with a 93% accuracy [17]. However, multi-institutional 
validation showed an accuracy of only 34% to 46% [5, 14, 
17]. Unfortunately, as reported by several studies, it is not 
Figure 3. The distribution of preoperative and surgical stages
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possible to predict with high accuracy which patients can be 
optimally debulked [5, 6].
In our study, when all parameters used for preoperative 
determination of the extent of the disease are taken into 
account, we observed that CT has a sensitivity of 91% and 
specificity of 71%, a finding which is consistent with previous 
reports [5, 8, 18]. In addition, we found that CT could detect 
adnexal masses quite successfully, with a 93% sensitivity 
and a 70% specificity, as is consistent with previous reports, 
but it does not show sufficient sensitivity and specificity 
to determine local tumor dispersion like uterine and tubal 
involvement, pelvic fat plan obliteration and bladder metas-
tases [5, 19, 20]. As it has been suggested before, we think MRI 
may yield more useful results regarding these areas [21, 22].
CT findings were found to have high predictive value for 
the parameters of peritoneal involvement such as ascites, 
peritoneal carcinomatosis and omental involvement, but 
also it was found to be insufficient to detect peritoneal 
implants < 5 mm, involvement of the intestinal surface and 
mesentery. It was concluded that CT did not have adequate 
sensitivity for these areas, as was pointed out in previous 
reports [15, 23, 24]. Again, as shown in many previous stud-
ies, CT had a low sensitivity for detection of retroperitoneal 
lymph node involvement and diaphragmatic metastasis 
[13]. We observed that CT had a 50% sensitivity for detection 
of liver metastasis. Previous reports show great variability 
among different experienced radiologists regarding detec-
tion of liver metastasis [24].
Based on CT findings, the cut off value for serum CA-
125 level was calculated as 76.5 IU/mL. Above this threshold, 
sensitivity and specificity of CT were calculated as 72.1% and 
85.7%, respectively (AUC = 0.798). CT findings were found 
to be statistically significantly correlated with intraoperative 
findings above this threshold (p = 0.001, p < 0.05).
In order to assess the predictability of preoperative CT 
examination for detecting potential complications of the 
surgery and additional requirement of interventions, we 
analyzed preoperative CT findings based on the gastroin-
testinal system, genitourinary system, and cardiovascular 
system complications and additional surgeries. We detected 
a statistically significant correlation between CT findings 
related to the involvement of small and large bowels and 
liver (superficial and parenchymal) with intraoperative com-
plications and additional surgical procedures (small and 
large bowel resection, liver resection). 
The current study examined multiple radiographic fea-
tures and clinical characteristics in an attempt to determine 
anatomical regions where CT is more successful in inter-
preting the findings more accurately. An important point 
of this study is that it was retrospective and thin-slice spiral 
multiplanar CT could not be used [25]. Also, the database 
incorporated the surgical results of different surgeons. 
Accurate evaluation is an important prerequisite to se-
lect the best treatment strategy, to identify appropriate 
patients for surgery, and to determine specific surgical pro-
cedures preoperatively. Therefore, evaluation by an appro-
priate preoperative test is critical and prospective studies 
may be warranted.
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